-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
-
Summary
-
Amneal Pharmaceuticals, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from Q2 2017 to Q3 2024.
- Amneal Pharmaceuticals, Inc. Nonoperating Income (Expense) for the quarter ending September 30, 2024 was -$73.4M, a 39.3% decline year-over-year.
- Amneal Pharmaceuticals, Inc. Nonoperating Income (Expense) for the twelve months ending September 30, 2024 was -$311M, a 63% decline year-over-year.
- Amneal Pharmaceuticals, Inc. annual Nonoperating Income (Expense) for 2023 was -$245M, a 59.7% decline from 2022.
- Amneal Pharmaceuticals, Inc. annual Nonoperating Income (Expense) for 2022 was -$153M, a 26.2% decline from 2021.
- Amneal Pharmaceuticals, Inc. annual Nonoperating Income (Expense) for 2021 was -$121M, a 4.4% increase from 2020.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)